The drug-shock strategy was more effective for patients experiencing atrial fibrillation for the first time and for patients younger than 70 years, the researchers said. Both the anti-arrhythmia drug ...

Demonstrating one potential application of the technology, an automated algorithm tied to the KardiaBand wearable ECG (AliveCor) performed “reasonably well” at detecting A-fib in patients scheduled ...

Cardioversion is a treatment for a relatively common heart condition called atrial fibrillation. Through this procedure, an abnormally fast or slow heart rate is converted to a normal rhythm with the ...

Sinus rhythm was restored in an effective, safe and rapid manner using drug-shock or shock-only strategies among patients in the ED with acute atrial fibrillation, according to results of the RAFF-2 ...

LISBON — After delaying cardioversion based on a "wait-and-see" (WAS) approach for recent onset, symptomatic atrial fibrillation (AF) was just as good as acute cardioversion (AC) in getting patients ...

It's a funny name, isn't it? Cardioversion. A more honest way of describing the procedure would be to say that we are going to deliver a high-voltage shock to your chest. This will stop the heart's ...

Warfarin, dabigatran and rivaroxaban are safe periprocedural anticoagulation options for patients undergoing cardioversion or ablation for atrial fibrillation, according to researchers in Canada. “We ...

Cardioversion is a treatment given to patients who suffer from abnormal heartbeats (arrhythmias). The medical procedure is done by giving electric shocks to the heart through electrodes placed on the ...

(HealthDay News) — A delay to cardioversion of ≥12 hours from onset of acute atrial fibrillation symptoms is associated with a greater risk of thromboembolic complications, according to a research ...

The 204 people randomized to IV procainamide (plus electrical cardioversion if necessary, with up to three shocks) showed a 96% rate of conversion to sinus rhythm that was maintained for at least 30 ...

Cardioversion in atrial fibrillation (AF) is associated with an increased risk of thromboembolism. Current recommendations advise therapy with the anticoagulant warfarin both before and after ...